Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05014_nanopub.RALI7Jp7LIKPnQSE85I4iwXyhxsWjRT0k_vJd7rBqy7ZY#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05014 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05014 label "XL999 [drugbank:DB05014]" assertion.
- drugbank:DB05014 seeAlso DB05014 assertion.
- drugbank:DB05014 identifier "drugbank:DB05014" assertion.
- drugbank:DB05014 description "XL999 has the potential to provide benefit to patients with lung cancer and acute myelogenous leukemia. XL999 is a new chemical entity that inhibits a spectrum of receptor tyrosine kinases (RTKs) with growth promoting and angiogenic properties, including FGFR 1/3, PDGFRα/β, VEGFR2/KDR, KIT, and FLT3. XL999 also inhibits FLT4 and SRC. XL999 has the potential to prevent tumor growth — both directly by a novel effect on tumor cell proliferation and indirectly through inhibition of the host angiogenic response. XL999 induces a cell-cycle block by a mechanism distinct from those previously identified and exhibits broad antitumor activity in xenograft models." assertion.
- drugbank:DB05014 title "XL999" assertion.
- drugbank:DB05014 bio2rdf_vocabulary:identifier "DB05014" assertion.
- drugbank:DB05014 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05014 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05014" assertion.
- drugbank:DB05014 bio2rdf_vocabulary:x-identifiers.org DB05014 assertion.
- drugbank:DB05014 drugbank_vocabulary:drugbank-id "DB05014" assertion.
- drugbank:DB05014 drugbank_vocabulary:x-cas cas:921206-68-0 assertion.